PAI
EW icon

Pittenger & Anderson Inc’s Edwards Lifesciences EW Stock Holding History

Pittenger & Anderson Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$537K Sell
5,934
-20,252
-77% -$1.7M 0.02% 192
2026
Q1 		$2.1M Buy
26,186
+8,669
+49% +$715K 0.08% 139
2025
Q4 		$1.49M Buy
17,517
+516
+3% +$42.3K 0.06% 148
2025
Q3 		$1.32M Buy
17,001
+1,887
+12% +$147K 0.05% 154
2025
Q2 		$1.18M Hold
15,114
– – 0.04% 151
2025
Q1 		$1.1M Buy
15,114
+100
+0.7% +$7.16K 0.04% 149
2024
Q4 		$1.11M Buy
15,014
+5,609
+60% +$393K 0.04% 153
2024
Q3 		$621K Sell
9,405
-8,761
-48% -$637K 0.02% 175
2024
Q2 		$1.68M Buy
18,166
+7,461
+70% +$661K 0.07% 143
2024
Q1 		$1.02M Buy
10,705
+3,887
+57% +$327K 0.04% 153
2023
Q4 		$520K Buy
+6,818
New +$474K 0.02% 177

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Pittenger & Anderson Inc's EW Position: Q2 2026 in Review

Pittenger & Anderson Inc reduced its Edwards Lifesciences (EW) stake by 77% in Q2 2026, selling an estimated $1.7M and leaving 5,934 shares worth $537K. The position accounts for 0.02% of the portfolio, ranked #192.

Pittenger & Anderson Inc first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.1M in Q1 2026. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Pittenger & Anderson Inc held 5,934 shares of Edwards Lifesciences worth $537K as of Q2 2026.
  • Pittenger & Anderson Inc sold 20,252 Edwards Lifesciences shares in Q2 2026, an estimated $1.7M.
  • Edwards Lifesciences made up 0.02% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #192 holding.
  • Pittenger & Anderson Inc first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Pittenger & Anderson Inc's Edwards Lifesciences position peaked at $2.1M in Q1 2026.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.